FREEZE-AFIB Post-Market Study

NCT05089877 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 39

Last updated 2025-01-13

Study results available
· View outcomes & findings →

Summary

This study is proposed herein is to gather clinical data on the safety and performance of the CRYOF device.

Conditions

Interventions

DEVICE

Surgical Ablation

The AtriCure cryoICE® cryoFORMTM cryoablation probe is used in the cryosurgical treatment of cardiac arrhythmias by freezing target tissues, creating an inflammatory response (cryonecrosis) that blocks the electrical conduction pathway.

Sponsors & Collaborators

  • AtriCure, Inc.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-29
Primary Completion
2023-03-31
Completion
2023-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05089877 on ClinicalTrials.gov